New application of Chinese medicinal composition to treatment of vascular dementia
A technology of vascular dementia and composition, which is applied in the new pharmaceutical application field of Peiyuan Tongnao pharmaceutical composition, and can solve the problems of undisclosed advanced neurocognitive dysfunction and undisclosed Peiyuan Tongnao preparation vascular dementia, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example
[0040] Select 68 patients with mild and moderate vascular dementia who meet the diagnostic criteria, and randomly divide them into a treatment group and a control group at a ratio of 1:1. The diagnostic criteria of vascular dementia can refer to the fourth national cerebrovascular disease academic conference of the Chinese Medical Association. Meeting to determine the diagnostic criteria for vascular dementia (1995). The treatment group consisted of 34 cases, including 20 males and 14 females, with an average age of (69±8.6) years, an average course of disease of (1.2±0.6) years, 18 cases of mild dementia, 16 cases of moderate dementia, of which autosomal dominant Arterial disease (CADASIL) 7 people and amyloid cerebrovascular disease 5 people. The control group consisted of 34 cases, including 19 males and 15 females, with an average age of (67.95±9.78) years, an average disease duration of (1.23±0.41) years, 21 cases of mild dementia, 13 cases of moderate dementia, autosomal...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com